3Mc Clave SA,Martindale RG,Vanek VW,et al.Guidelines for the provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society for Critical Care Medicine(SCCM)and American Society for Parenteral and Enteral Nutrition(A.S.P.E.N.)[J].JPEN J Parenteral Enteral Nutr,2009,33(3):277-316.
8Netto AB,Taly AB,Kulkami GB,Uma Maheshwara Rao GS,Rao S.Prognosis of patients with Guillain~Barre syndrome requiring mechanical ventilation[J].Neurol India,2011,59(5):707-711.
9Ramos-Casals M,Brito-Zerón P,Muoz S.Autoimmune disease induced by TNF-targeted therapies:analysis of 233 cases[J].Medicine(Baltimore),2007,86(4):242-251.
10Tan CS,Koralnik IJ.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus:clinical features and pathogenesis[J].Lancet Neurol,2010,9(4):425-437.
9Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis, 1997,176 Suppl 2 : S92-98.
10Nachamkin I, Barbosa PA, Ung H, et al. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology, 2007,69 : 1665-1671.
